CD4 and HIV-1 infection: This vaccine showed moderate protection against HIV-1 infection and, more interestingly, revealed that most vaccinated HIV-negative individuals presented predominantly polyfunctional effector CD4+ T cell responses against the V2 region of the envelope protein (140, 141).